Aerosolized anti-T-cell-receptor antibodies are effective against airway inflammation and hyperreactivity

Michael Lahn, Arihiko Kanehiro, Youn Soo Hahn, J. M. Wands, M. Kemal Aydintug, Rebecca L. O'Brien, Erwin W. Gelfand, Willi K. Born

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Aerosolized monoclonal antibodies (mAbs) specific for T-cell receptors (TCR) were used to manipulate T-cell function in airways of ovalbumin (OVA)-sensitized and -challenged mice with airway hyperresponsiveness (AHR). The inhaled mAbs were found to be effective at low doses, had little or no systemic effect and specifically abrogated both effector and regulatory functions of the targeted T cells. Specific mAbs targeting αβ T cells suppressed and those targeting γδ T cells enhanced AHR. Moreover, specific mAbs directed against subsets of γδ T cells varied in their effect on AHR. Using this approach of targeting either αβ or γδ T cells reduced airway eosinophila, although the effect of mAbs specific for αβ T cells was stronger. The use of aerosolized anti-TCR mAbs may offer an effective approach for the treatment of airway inflammation and AHR.

Original languageEnglish
Pages (from-to)49-55
Number of pages7
JournalInternational Archives of Allergy and Immunology
Volume134
Issue number1
DOIs
Publication statusPublished - 2004
Externally publishedYes

Fingerprint

T-Cell Antigen Receptor
Monoclonal Antibodies
Inflammation
T-Lymphocytes
Antibodies
Ovalbumin
T-Lymphocyte Subsets
Thomsen-Friedenreich antibodies

Keywords

  • Aerosolized monoclonal antibodies
  • Airway hyperreactivity
  • Inflammation, airways
  • Ovalbumin
  • T cell receptor

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Lahn, M., Kanehiro, A., Hahn, Y. S., Wands, J. M., Aydintug, M. K., O'Brien, R. L., ... Born, W. K. (2004). Aerosolized anti-T-cell-receptor antibodies are effective against airway inflammation and hyperreactivity. International Archives of Allergy and Immunology, 134(1), 49-55. https://doi.org/10.1159/000077533

Aerosolized anti-T-cell-receptor antibodies are effective against airway inflammation and hyperreactivity. / Lahn, Michael; Kanehiro, Arihiko; Hahn, Youn Soo; Wands, J. M.; Aydintug, M. Kemal; O'Brien, Rebecca L.; Gelfand, Erwin W.; Born, Willi K.

In: International Archives of Allergy and Immunology, Vol. 134, No. 1, 2004, p. 49-55.

Research output: Contribution to journalArticle

Lahn, M, Kanehiro, A, Hahn, YS, Wands, JM, Aydintug, MK, O'Brien, RL, Gelfand, EW & Born, WK 2004, 'Aerosolized anti-T-cell-receptor antibodies are effective against airway inflammation and hyperreactivity', International Archives of Allergy and Immunology, vol. 134, no. 1, pp. 49-55. https://doi.org/10.1159/000077533
Lahn, Michael ; Kanehiro, Arihiko ; Hahn, Youn Soo ; Wands, J. M. ; Aydintug, M. Kemal ; O'Brien, Rebecca L. ; Gelfand, Erwin W. ; Born, Willi K. / Aerosolized anti-T-cell-receptor antibodies are effective against airway inflammation and hyperreactivity. In: International Archives of Allergy and Immunology. 2004 ; Vol. 134, No. 1. pp. 49-55.
@article{cf78bd98fcf641d797e3b77337170a79,
title = "Aerosolized anti-T-cell-receptor antibodies are effective against airway inflammation and hyperreactivity",
abstract = "Aerosolized monoclonal antibodies (mAbs) specific for T-cell receptors (TCR) were used to manipulate T-cell function in airways of ovalbumin (OVA)-sensitized and -challenged mice with airway hyperresponsiveness (AHR). The inhaled mAbs were found to be effective at low doses, had little or no systemic effect and specifically abrogated both effector and regulatory functions of the targeted T cells. Specific mAbs targeting αβ T cells suppressed and those targeting γδ T cells enhanced AHR. Moreover, specific mAbs directed against subsets of γδ T cells varied in their effect on AHR. Using this approach of targeting either αβ or γδ T cells reduced airway eosinophila, although the effect of mAbs specific for αβ T cells was stronger. The use of aerosolized anti-TCR mAbs may offer an effective approach for the treatment of airway inflammation and AHR.",
keywords = "Aerosolized monoclonal antibodies, Airway hyperreactivity, Inflammation, airways, Ovalbumin, T cell receptor",
author = "Michael Lahn and Arihiko Kanehiro and Hahn, {Youn Soo} and Wands, {J. M.} and Aydintug, {M. Kemal} and O'Brien, {Rebecca L.} and Gelfand, {Erwin W.} and Born, {Willi K.}",
year = "2004",
doi = "10.1159/000077533",
language = "English",
volume = "134",
pages = "49--55",
journal = "International Archives of Allergy and Immunology",
issn = "1018-2438",
publisher = "S. Karger AG",
number = "1",

}

TY - JOUR

T1 - Aerosolized anti-T-cell-receptor antibodies are effective against airway inflammation and hyperreactivity

AU - Lahn, Michael

AU - Kanehiro, Arihiko

AU - Hahn, Youn Soo

AU - Wands, J. M.

AU - Aydintug, M. Kemal

AU - O'Brien, Rebecca L.

AU - Gelfand, Erwin W.

AU - Born, Willi K.

PY - 2004

Y1 - 2004

N2 - Aerosolized monoclonal antibodies (mAbs) specific for T-cell receptors (TCR) were used to manipulate T-cell function in airways of ovalbumin (OVA)-sensitized and -challenged mice with airway hyperresponsiveness (AHR). The inhaled mAbs were found to be effective at low doses, had little or no systemic effect and specifically abrogated both effector and regulatory functions of the targeted T cells. Specific mAbs targeting αβ T cells suppressed and those targeting γδ T cells enhanced AHR. Moreover, specific mAbs directed against subsets of γδ T cells varied in their effect on AHR. Using this approach of targeting either αβ or γδ T cells reduced airway eosinophila, although the effect of mAbs specific for αβ T cells was stronger. The use of aerosolized anti-TCR mAbs may offer an effective approach for the treatment of airway inflammation and AHR.

AB - Aerosolized monoclonal antibodies (mAbs) specific for T-cell receptors (TCR) were used to manipulate T-cell function in airways of ovalbumin (OVA)-sensitized and -challenged mice with airway hyperresponsiveness (AHR). The inhaled mAbs were found to be effective at low doses, had little or no systemic effect and specifically abrogated both effector and regulatory functions of the targeted T cells. Specific mAbs targeting αβ T cells suppressed and those targeting γδ T cells enhanced AHR. Moreover, specific mAbs directed against subsets of γδ T cells varied in their effect on AHR. Using this approach of targeting either αβ or γδ T cells reduced airway eosinophila, although the effect of mAbs specific for αβ T cells was stronger. The use of aerosolized anti-TCR mAbs may offer an effective approach for the treatment of airway inflammation and AHR.

KW - Aerosolized monoclonal antibodies

KW - Airway hyperreactivity

KW - Inflammation, airways

KW - Ovalbumin

KW - T cell receptor

UR - http://www.scopus.com/inward/record.url?scp=2542640105&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542640105&partnerID=8YFLogxK

U2 - 10.1159/000077533

DO - 10.1159/000077533

M3 - Article

VL - 134

SP - 49

EP - 55

JO - International Archives of Allergy and Immunology

JF - International Archives of Allergy and Immunology

SN - 1018-2438

IS - 1

ER -